安道麥A(000553.SZ):荊州基地乙酰甲胺磷項目試生產
格隆匯11月19日丨安道麥A(000553.SZ)宣佈,公司位於湖北省的荊州基地新廠區年產30,000噸乙酰甲胺磷項目完成工程主體建設及設備安裝、調試工作,試生產方案已經專家評審通過,並進入試生產階段,標誌着荊州基地新廠區正式投入運營。
荊州基地新廠區位於政府批准的工業園區內,是公司全球生產運營佈局的重要組成部分。經過搬遷及升級改造的新廠區預計有望顯著提升運營效率,降低運營成本,並做好準備接收更多來自公司強大在研產品線的新增原藥產品。
鑑於荊州基地新廠區於近期投入生產,目前產能恢復尚處於初始階段,產量相對較低,公司預計產量將在未來數月逐步提高。隨着新廠區生產的恢復,公司在老廠區停產期間為滿足銷售需求對外採購而承受的額外採購成本將逐漸減少,停工損失預計亦將隨着未來產能利用率提升而逐漸減少。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.